Inspection Record

L. Perrigo Co — FDA 483 Findings

US FDAInspected 2015-07-11Published 2024-01-17 7 findingsComplaint and recall handlingDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Complaint and recall handling

Written procedures describing the handling of complaints do not include provisions for review by the quality control unit o f any complaint involving the possible failure of a drug product to meet any of its specifications and a determination as to th e need for an investigation of any unexplained discrepancy .

2Complaint and recall handling

Procedures describing the handling of wri tten and oral complaints related to drug products are deficiently wri tten or followed.

3Deviation, CAPA, and investigation

The w ritten record did not include the reason an investigation was found not to be necessa ry and name of the responsible person making the determination not to conduct an investigation when an investigation into unexplained discrepancies wa s not conducted.

4Deviation, CAPA, and investigation

Investigations of an unexplained discrepancy did not extend to other drug products that may have been associated with th e specific failure or discrepancy .

5Complaint and recall handling

Complaint procedures are defi cient in that written complaint files are not maintained at the manufacturing site nor were the y readily available from their off-site location .

6Complaint and recall handling

Complaint records are deficient in that they do not document the reason and the individual making the decision not t o conduct a complaint investigation .

7Complaint and recall handling

Complaint records are deficient in that they do not include the known reply to complainant .

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

L. Perrigo Co company profile — full history US FDA documents, 2024 Go to Findings search